CASI Pharmaceuticals, Inc.
SEC Filing List
CASI CIK: 0000895051
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SC 13D/A | Amendment to Schedule filed to report ac... | Sparkle Byte Ltd | DAVIS POLK & WARDWELL LLP 01/FA /fa | 02/20/2024 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 03/24/2023 | ||
| 15-12G | Notice of termination of registration of... | Toppan Merrill/FA | 03/22/2023 | ||
| S-8 POS | Post-effective amendment to a S-8 regist... | Toppan Merrill/FA | 03/21/2023 | ||
| 8-K | Current report filing | Toppan Merrill/FA | 03/21/2023 | ||
| S-8 POS | Post-effective amendment to a S-8 regist... | Toppan Merrill/FA | 03/21/2023 | ||
| S-8 POS | Post-effective amendment to a S-8 regist... | Toppan Merrill/FA | 03/21/2023 | ||
| S-8 POS | Post-effective amendment to a S-8 regist... | Toppan Merrill/FA | 03/21/2023 | ||
| POS AM | Post-effective amendment to a registrati... | Toppan Merrill/FA | 03/21/2023 | ||
| SC 13D/A | Amendment to Schedule filed to report ac... | Ho Chi Sing | DAVIS POLK & WARDWELL LLP 01/FA | 02/21/2023 | |
| No record found. | |||||
| Load More | |||||
